- Home
- AKAM vs ASND Comparison
AKAM vs ASND Comparison
Compare AKAM & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAM
- ASND
- Stock Information
- Founded
- AKAM 1998
- ASND 2006
- Country
- AKAM United States
- ASND Denmark
- Employees
- AKAM N/A
- ASND N/A
- Industry
- AKAM Business Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- AKAM Consumer Discretionary
- ASND Health Care
- Exchange
- AKAM Nasdaq
- ASND Nasdaq
- Market Cap
- AKAM 12.2B
- ASND 9.8B
- IPO Year
- AKAM 1999
- ASND 2015
- Fundamental
- Price
- AKAM $78.38
- ASND $176.90
- Analyst Decision
- AKAM Buy
- ASND Strong Buy
- Analyst Count
- AKAM 22
- ASND 16
- Target Price
- AKAM $105.15
- ASND $218.19
- AVG Volume (30 Days)
- AKAM 2.3M
- ASND 411.5K
- Earning Date
- AKAM 08-07-2025
- ASND 05-01-2025
- Dividend Yield
- AKAM N/A
- ASND N/A
- EPS Growth
- AKAM N/A
- ASND N/A
- EPS
- AKAM 2.97
- ASND N/A
- Revenue
- AKAM $4,019,337,000.00
- ASND $398,509,511.00
- Revenue This Year
- AKAM $5.61
- ASND $75.05
- Revenue Next Year
- AKAM $5.41
- ASND $78.14
- P/E Ratio
- AKAM $26.20
- ASND N/A
- Revenue Growth
- AKAM 3.51
- ASND 12.06
- 52 Week Low
- AKAM $67.51
- ASND $111.09
- 52 Week High
- AKAM $106.80
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- AKAM 51.57
- ASND 60.02
- Support Level
- AKAM $76.86
- ASND $169.65
- Resistance Level
- AKAM $80.03
- ASND $178.62
- Average True Range (ATR)
- AKAM 1.55
- ASND 6.77
- MACD
- AKAM 0.24
- ASND 0.03
- Stochastic Oscillator
- AKAM 69.10
- ASND 82.61
About AKAM Akamai Technologies Inc.
Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.